| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.39 | 2e-10 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-06 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.32 | 8e-06 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.31 | 7e-05 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.0001 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |